en ENGLISH
eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
SCImago Journal & Country Rank
Poleć ten artykuł:
Udostępnij:
Artykuł przeglądowy

Zaburzenia ze spektrum autyzmu i wrodzone choroby metaboliczne: czy istnieją cechy wspólne?

Patryk Lipiński
1, 2

  1. Institute of Clinical Sciences, Maria-Sklodowska-Curie Medical Academy, Warsaw, Poland
  2. Department of Paediatrics, Bielanski Hospital, Warsaw, Poland
Data publikacji online: 2025/03/13
Plik artykułu:
- 0334_Autism spectrum.pdf  [0.73 MB]
Pobierz cytowanie
 
Metryki PlumX:
 
1. Hyman SL, Levy SE, Myers SM. Council on children with disabilities, section on developmental and behavioral pediatrics. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics 2020; 145: e20193447. doi: 10.1542/peds.2019-3447.
2. Rosen NE, Lord C, Volkmar FR. The Diagnosis of Autism: From Kanner to DSM-III to DSM-5 and Beyond. J Autism Dev Disord 2021; 51: 4253–4270. doi: 10.1007/s10803-021-04904-1.
3. Wing L, Gould J, Gillberg C. Autism spectrum disorders in the DSM-V: better or worse than the DSM-IV? Res Dev Disabil 2011; 32: 768–773. doi: 10.1016/j.ridd.2010.11.003.
4. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. American Psychiatric Association, Washington, DC, USA 2022. Text Revision.
5. Kamp-Becker I, Albertowski K, Becker J, et al. Diagnostic accuracy of the ADOS and ADOS-2 in clinical practice. Eur Child Adolesc Psychia-try 2018; 27: 1193–1207. doi: 10.1007/s00787-018-1143-y.
6. Ferreira CR, Rahman S, Keller M, Zschocke J; ICIMD Advisory Group. An international classification of inherited metabolic disorders (ICIMD). J Inherit Metab Dis 2021; 44: 164–177. doi: 10.1002/jimd.12348.
7. Senarathne UD, Indika NR, Jezela-Stanek A, et al. Biochemical, Genetic and Clinical Diagnostic Approaches to Autism-Associated Inherited Metabolic Disorders. Genes (Basel) 2023; 14: 803. doi: 10.3390/genes14040803.
8. Schaefer GB, Mendelsohn NJ; Professional Practice and Guidelines Committee. Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions. Genet Med 2013; 15: 399–407. doi:10.1038/gim.2013.32.
9. Manning M, Hudgins L; Professional Practice and Guidelines Committee. Array-based technology and recommendations for utilization in medical genetics practice for detection of chromosomal abnormalities. Genet Med 2010; 12: 742–745. doi: 10.1097/GIM.0b013e3181f8baad.
10. Waggoner D, Wain KE, Dubuc AM, et al. ACMG Professional Practice and Guidelines Committee. Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2018; 20: 1105–1113. doi: 10.1038/s41436-018-0040-6.
11. Genovese A, Butler MG. The Autism Spectrum: Behavioral, Psychiatric and Genetic Associations. Genes (Basel) 2023; 14: 677. doi: 10.3390/genes14030677.
12. Riggs ER, Andersen EF, Cherry AM, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020; 22: 245–257. doi: 10.1038/s41436-019-0686-8.
13. Butler MG, Rafi SK, Manzardo AM. High-resolution chromosome ideogram representation of currently recognized genes for autism spectrum disorders. Int J Mol Sci 2015; 16: 6464–6495. doi: 10.3390/ijms16036464.
14. Chiurazzi P, Kiani AK, Miertus J, et al. Genetic analysis of intellectual disability and autism. Acta Biomed 2020; 91: e2020003. doi: 10.23750/abm.v91i13-S.10684.
15. Srivastava S, Love-Nichols JA, Dies KA, et al.; NDD Exome Scoping Review Work Group. Meta-analysis and multidisciplinary consensus statement: exome sequencing is a first-tier clinical diagnostic test for individuals with neurodevelopmental disorders. Genet Med 2019; 21: 2413–2421. doi: 10.1038/s41436-019-0554-6.
16. Manickam K, McClain MR, Demmer LA, et al.; ACMG Board of Directors. Exome and genome sequencing for pediatric patients with congenital anomalies or intellectual disability: an evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2021; 23: 2029–2037. doi: 10.1038/s41436-021-01242-6.
17. Horvath GA, Stowe RM, Ferreira CR, Blau N. Clinical and biochemical footprints of inherited metabolic diseases. III. Psychiatric presentations. Mol Genet Metab 2020; 130: 1–6. doi: 10.1016/j.ymgme.2020.02.007.
18. Žigman T, Petković Ramadža D, Šimić G, Barić I. Inborn Errors of Metabolism Associated With Autism Spectrum Disorders: Approaches to Intervention. Front Neurosci 2021; 15: 673600. doi: 10.3389/fnins.2021.673600.
19. Gaspar JM, Carvalho HM, Camacho-Morales A. Editorial: Metabolic Disorders Associated With Autism Spectrum Disorders: Approaches for Intervention. Front Neurosci 2021; 15: 809978. doi: 10.3389/fnins.2021.809978.
20. Moravej H, Inaloo S, Nahid S, et al. Inborn Errors of Metabolism Associated With Autism Among Children: A Multicenter Study from Iran. Indian Pediatr 2023; 60: 193–196.
21. El Fotoh WMMA, El Naby SAA, Abd El Hady NMS. Autism Spectrum Disorders: The Association with Inherited Metabolic Disorders and Some Trace Elements. A Retrospective Study. CNS Neurol Disord Drug Targets 2019; 18: 413–420. doi: 10.2174/1871527318666190430162724.
22. Schiff M, Benoist JF, Aïssaoui S, et al. Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One 2011; 6: e21932. doi: 10.1371/journal.pone.0021932.
23. İnci A, Özaslan A, Okur İ, et al. Autism: Screening of inborn errors of metabolism and unexpected results. Autism Res 2021; 14: 887–896. doi: 10.1002/aur.2486.
24. Shi H, Wang J, Zhao Z. [Analysis of inborn error metabolism in 277 children with autism spectrum disorders from Hainan]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2019; 36: 870–873. doi: 10.3760/cma.j.issn.1003-9406.2019.09.004.
25. Ververi A, Vargiami E, Papadopoulou V, et al. Clinical and laboratory data in a sample of Greek children with autism spectrum disorders. J Autism Dev Disord 2012; 42: 1470–1476. doi: 10.1007/s10803-011-1414-7.
26. Spilioti M, Evangeliou AE, Tramma D, et al. Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD). Front Hum Neurosci 2013; 7: 858. doi: 10.3389/fnhum.2013.00858.
27. Kiykim E, Zeybek CA, Zubarioglu T, et al. Inherited metabolic disorders in Turkish patients with autism spectrum disorders. Autism Res 2016; 9: 217–223. doi: 10.1002/aur.1507.
28. Campistol J, Díez-Juan M, Callejón L, et al. Inborn error metabolic screening in individuals with nonsyndromic autism spectrum disorders. Dev Med Child Neurol 2016; 58: 842–847. doi: 10.1111/dmcn.13114.
29. Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. J Child Neurol 2008; 23: 307–314. doi: 10.1177/0883073807308698.
30. Saudubray JM, Garcia-Cazorla À. Inborn Errors of Metabolism Overview: Pathophysiology, Manifestations, Evaluation, and Management. Pediatr Clin North Am 2018; 65: 179–208. doi: 10.1016/j.pcl.2017.11.002.
31. Ghaziuddin M, Al-Owain M. Autism spectrum disorders and inborn errors of metabolism: an update. Pediatr Neurol 2013; 49: 232–236. doi: 10.1016/j.pediatrneurol.2013.05.013.
32. Wijburg FA, Węgrzyn G, Burton BK, Tylki-Szymańska A. Mucopolysaccharidosis type III (Sanfilippo syndrome) and misdiagnosis of idiopathic developmental delay, attention deficit/hyperactivity disorder or autism spectrum disorder. Acta Paediatr 2013; 102: 462–470. doi: 10.1111/apa.12169.

© 2025 Termedia Sp. z o.o.
Developed by Bentus.